Last reviewed · How we verify
Matching placebo to Seltorexant — Competitive Intelligence Brief
phase 3
Neurology
Small molecule
Live · refreshed every 30 min
Target snapshot
Matching placebo to Seltorexant (Matching placebo to Seltorexant) — Janssen Research & Development, LLC. This is a matching placebo control formulation designed to mimic Seltorexant, an orexin 2 receptor antagonist used in sleep disorder trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Matching placebo to Seltorexant TARGET | Matching placebo to Seltorexant | Janssen Research & Development, LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Matching placebo to Seltorexant CI watch — RSS
- Matching placebo to Seltorexant CI watch — Atom
- Matching placebo to Seltorexant CI watch — JSON
- Matching placebo to Seltorexant alone — RSS
Cite this brief
Drug Landscape (2026). Matching placebo to Seltorexant — Competitive Intelligence Brief. https://druglandscape.com/ci/matching-placebo-to-seltorexant. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab